XML 37 R22.htm IDEA: XBRL DOCUMENT v3.25.0.1
Note 15 - Earnings Per Share
12 Months Ended
Nov. 30, 2024
Notes to Financial Statements  
Earnings Per Share [Text Block]

15.

EARNINGS PER SHARE

 

For the year ended November 30, 2024, the Company recorded net income and, as such, used diluted weighted-average common shares outstanding when calculating diluted income per share for the year ended November 30, 2024. Stock options and RSUs that could potentially dilute basic earnings per share (“EPS”) in the future are included in the computation of diluted income per share. For the year ended November 30, 2023, the Company recorded net loss available to common shareholders. As such, because the dilution impact from potential common shares was antidilutive, the Company used basic weighted-average common shares outstanding, rather than diluted weighted-average common shares outstanding when calculating diluted loss per share for the year ended November 30, 2023.

 

  

November 30,

 
  

2024

  

2023

 

Net income (loss)

 $12,792  $(8,192)
         

Weighted-average number of shares used in computing net loss per share, basic

  22,504,938   21,919,624 

Weighted-average number of shares used in computing net loss per share, diluted

  23,139,549   21,919,624 

Net income (loss) per share - basic

 $0.57  $(0.37)

Net income (loss) per share - diluted

 $0.55  $(0.37)

 

The Company’s potential dilutive securities, which include stock options and RSUs have been excluded from the computation of diluted net income (loss) per share as the effect would be anti-dilutive. Therefore, the weighted-average number of common shares outstanding used to calculate both basic and diluted net income (loss) per share attributable to common stockholders is the same. The following potential common shares, presented based on amounts outstanding at each period end, were excluded from the calculation of diluted net income (loss) per share attributable to common stockholders for the periods indicated because including them would have had an anti-dilutive effect:

 

  

November 30,

 
  

2024

  

2023

 

Stock Options

  256,423   1,384,666 

Restricted Stock

  19,374   578,250 

Total

  275,797   1,962,916